The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Measures of abstinence in clinical trials: issues and recommendations
Abstract
A workgroup formed by the Society for Research on Nicotine and Tobacco reviewed the literature on abstinence measures used in trials of smoking cessation interventions. We recommend that trials report multiple measures of abstinence. However, at a minimum we recommend that trial: (a) report prolonged abstinence (i.e., sustained abstinence after an initial period in which smoking is not counted as a failure) as the preferred measure, plus point prevalence as a secondary measure; (b) use 7 consecutive days of smoking or smoking on > or = 1 day of 2 consecutive weeks to define treatment failure; (c) include non-cigarette tobacco use, but not nicotine medications in definitions of failure; and (d) report results from survival analysis to describe outcomes more fully. Trials of smokers willing to set a quit date should tie all follow-ups to the quit date and report 6- and/or 12-month abstinence rates. For these trials, we recommend an initial 2-week grace period for prolonged abstinence definitions; however, the period may vary, depending on the presumed mechanism of the treatment. Trials of smokers who may not be currently trying to quit should tie follow-up to the initiation of the intervention and should report a prolonged abstinence measure of > or = 6-month duration and point prevalence rates at 6- and 12-month follow-ups. The grace period for these trials will depend on the time necessary for treatment dissemination, which will vary depending on the treatment, setting, and population. Trials that use short-term follow-ups (< or = 3 months) to demonstrate possible efficacy should report a prolonged abstinence measure of > or = 4 weeks. We again recommend a 2-week grace period; however, that period can vary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treating Tobacco Use and Dependence
(2008) · Pediatrics · doi:10.1542/peds.2008-1627 · Cited by 2,697
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Assessing outcome in smoking cessation studies.
Velicer, W. F., Prochaska, J. O., Rossi, J. S., & Snow, M. G. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.111.1.23 · Cited by 833
Kottke, T. E. (1988) · JAMA · doi:10.1001/jama.259.19.2883 · Cited by 741
Prochaska, J. O., DiClemente, C. C., Velicer, W. F., & Rossi, J. S. (1993) · Health Psychology · doi:10.1037/0278-6133.12.5.399 · Cited by 621
Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation
Silagy, C., Mant, D., Fowler, G., & Lodge, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90933-4 · Cited by 481
An Analysis of the Effectiveness of Interventions Intended to Help People Stop Smoking
Law, M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.18.1933 · Cited by 467
Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1758 · Cited by 425
Predicting Smoking Cessation: Who Will Quit With and Without the Nicotine Patch
Kenford, S. L. (1994) · JAMA · doi:10.1001/jama.271.8.589 · Cited by 405
The Effectiveness of the Nicotine Patch for Smoking Cessation: A Meta-analysis
Fiore, M. C. (1994) · JAMA · doi:10.1001/jama.1994.03510480064036 · Cited by 345
Cited by
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Self-citationOutcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Change in mental health after smoking cessation: systematic review and meta-analysis
Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014) · BMJ · doi:10.1136/bmj.g1151 · Cited by 1,039
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914
“Smoking lapses were defined as any discrete instances of smoking (even a puff of a cigarette) post-TQD, while relapses were defined as smoking on seven or more consecutive days after TQD (Hughes et al., 2003).”
BackgroundA meta-analysis of computer-tailored interventions for health behavior change
Krebs, P., Prochaska, J. O., & Rossi, J. S. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.06.004 · Cited by 854
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747
Tonstad, S. (2006) · JAMA · doi:10.1001/jama.296.1.64 · Cited by 660
“7) [2-59] 28.”
Prochaska, J. J., Delucchi, K., & Hall, S. M. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.6.1144 · Cited by 590
Williams, G. C., McGregor, H. A., Sharp, D., Levesque, C., Kouides, R. W., Ryan, R. M., & Deci, E. L. (2006) · Health Psychology · doi:10.1037/0278-6133.25.1.91 · Cited by 582
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub7 · Cited by 433
Relapse and Relapse Prevention
Brandon, T. H., Vidrine, J. I., & Litvin, E. B. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091455 · Cited by 385
Randomized trial of four financial-incentive programs for smoking cessation
Halpern, S. D., French, B., Small, D. S., Saulsgiver, K., Harhay, M. O., Audrain-McGovern, J., Loewenstein, G., Brennan, T. A., Asch, D. A., & Volpp, K. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414293 · Cited by 379
“Not enrolled in CVS Caremark health care plan 139 (30) 136 (27) 151 (29) 180 (31) 146 (31)”
Moore, D., Aveyard, P., Connock, M., Wang, D., Fry-Smith, A., & Barton, P. (2009) · BMJ · doi:10.1136/bmj.b1024 · Cited by 372
“which reported only point prevalence of cessation at end of follow-up, we focused on sustained cessation from smoking, widely considered the superior outcome measure for effectiveness.”
BackgroundPiasecki, T. M. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2005.11.007 · Cited by 370
Tobacco cessation interventions for young people
Grimshaw, G., & Stanton, A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003289.pub4 · Cited by 357
The English smoking treatment services: one‐year outcomes
Ferguson, J., Bauld, L., Chesterman, J., & Judge, K. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01028.x · Cited by 347
Incentives for smoking cessation
Cahill, K., Hartmann-Boyce, J., & Perera, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004307.pub5 · Cited by 324
Clinical correlates of co‐occurring cannabis and tobacco use: a systematic review
Peters, E. N., Budney, A. J., & Carroll, K. M. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03843.x · Cited by 320
Strecher, V. J., Shiffman, S., & West, R. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01093.x · Cited by 308
Lerman, C., Schnoll, R. A., Hawk, L. W., Cinciripini, P., George, T. P., Wileyto, E. P., Swan, G. E., Benowitz, N. L., Heitjan, D. F., & Tyndale, R. F. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70294-2 · Cited by 300
Self-citationMacPherson, L., Tull, M. T., Matusiewicz, A. K., Rodman, S., Strong, D. R., Kahler, C. W., Hopko, D. R., Zvolensky, M. J., Brown, R. A., & Lejuez, C. W. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0017939 · Cited by 293
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation
LERMAN, C., TYNDALE, R., PATTERSON, F., WILEYTO, E., SHIELDS, P., PINTO, A., & BENOWITZ, N. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.02.006 · Cited by 280
Smoking Cessation Interventions for Hospitalized Smokers: A Systematic Review
Rigotti, N. A., Munafo, M. R., & Stead, L. F. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.1950 · Cited by 273
Interventions to reduce harm from continued tobacco use
Lindson-Hawley, N., Hartmann-Boyce, J., Fanshawe, T. R., Begh, R., Farley, A., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005231.pub3 · Cited by 273
Interventions for tobacco cessation in the dental setting
Carr, A. B., & Ebbert, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005084.pub3 · Cited by 255
History of depression and smoking cessation outcome: A meta-analysis.
Hitsman, B., Borrelli, B., McChargue, D. E., Spring, B., & Niaura, R. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.657 · Cited by 253
Self-citationDoes smoking reduction increase future cessation and decrease disease risk? A qualitative review
Hughes, J., & Carpenter, M. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200600789726 · Cited by 238
Self-citationDynamic Self-Efficacy and Outcome Expectancies: Prediction of Smoking Lapse and Relapse.
Gwaltney, C. J., Shiffman, S., Balabanis, M. H., & Paty, J. A. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.4.661 · Cited by 232
Williams, G. C., Niemiec, C. P., Patrick, H., Ryan, R. M., & Deci, E. L. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9090-y · Cited by 201
Tobacco cessation interventions for young people.
Fanshawe, T. R., Halliwell, W., Lindson, N., Aveyard, P., Livingstone-Banks, J., & Hartmann-Boyce, J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003289.pub6 · Cited by 196
A randomized trial of nicotine-replacement therapy patches in pregnancy.
Coleman, T., Cooper, S., Thornton, J. G., Grainge, M. J., Watts, K., Britton, J., & Lewis, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109582 · Cited by 190
Smoking cessation interventions for smokers with current or past depression
van der Meer, R. M., Willemsen, M. C., Smit, F., & Cuijpers, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006102.pub2 · Cited by 159
Extended nortriptyline and psychological treatment for cigarette smoking
Hall, S. M., Humfleet, G. L., Reus, V. I., Muñoz, R. F., & Cullen, J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2100 · Cited by 158
A prospective examination of distress tolerance and early smoking lapse in adult self-quitters
Brown, R. A., Lejuez, C. W., Strong, D. R., Kahler, C. W., Zvolensky, M. J., Carpenter, L. L., Niaura, R., & Price, L. H. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp041 · Cited by 158
Self-citationProchaska, J. J., Hall, S. E., Delucchi, K., & Hall, S. M. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301403 · Cited by 149
Brown, R. A., Palm, K. M., Strong, D. R., Lejuez, C. W., Kahler, C. W., Zvolensky, M. J., Hayes, S. C., Wilson, K. G., & Gifford, E. V. (2008) · Behavior Modification · doi:10.1177/0145445507309024 · Cited by 145
Hernández-López, M., Luciano, M. C., Bricker, J. B., Roales-Nieto, J. G., & Montesinos, F. (2009) · Psychology of Addictive Behaviors · doi:10.1037/a0017632 · Cited by 137
Cinciripini, P. M., Robinson, J. D., Karam-Hage, M., Minnix, J. A., Lam, C., Versace, F., Brown, V. L., Engelmann, J. M., & Wetter, D. W. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.678 · Cited by 136
International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year
Muñoz, R. F., Barrera, A. Z., Delucchi, K., Penilla, C., Torres, L. D., & Pérez-Stable, E. J. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp090 · Cited by 127
Effectiveness of Extended-Duration Transdermal Nicotine Therapy: A Randomized Trial
Schnoll, R. A., Patterson, F., Wileyto, E. P., Heitjan, D. F., Shields, A. E., Asch, D. A., & Lerman, C. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-3-201002020-00005 · Cited by 126
The English smoking treatment services: short-term outcomes
Judge, K., Bauld, L., Chesterman, J., & Ferguson, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01027.x · Cited by 126
Lerman, C., Kaufmann, V., Rukstalis, M., Patterson, F., Perkins, K., Audrain-McGovern, J., & Benowitz, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00009 · Cited by 110
Moadel, A. B., Bernstein, S. L., Mermelstein, R. J., Arnsten, J. H., Dolce, E. H., & Shuter, J. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182645679 · Cited by 107
“The 3-month cessation endpoint is appropriate for a pilot trial, but more definitive work will require 6- or 12-month abstinence data.(40) Seven-day point-prevalence abstinence is a standard tobacco treatment outcome that has been closely correlated with 6-month continuous abstinence in prior large studies.”
MethodCooper, S., Lewis, S., Thornton, J. G., Marlow, N., Watts, K., Britton, J., Grainge, M. J., Taggar, J., Essex, H., Parrott, S., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18540 · Cited by 103
Smits, J. A. J., Zvolensky, M. J., Davis, M. L., Rosenfield, D., Marcus, B. H., Church, T. S., Powers, M. B., Frierson, G. M., Otto, M. W., Hopkins, L. B., et al. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000264 · Cited by 103
“As in past work (33), we used PPA and PA as the primary outcomes.”
MethodComparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation
Richter, K. P., Shireman, T. I., Ellerbeck, E. F., Cupertino, A. P., Catley, D., Cox, L. S., Preacher, K. J., Spaulding, R., Mussulman, L. M., Nazir, N., et al. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.3975 · Cited by 102
“Hypotheses 2-3: Prolonged Abstinence, Counseling Adherence, Pharmacotherapy Use Prolonged abstinence as defined in this study included a “grace period” of 1 month at the beginning of treatment to allow the treatment to take effect followed by continuous abstinence [27].”
BackgroundMethodComparing Two Web-Based Smoking Cessation Programs: Randomized Controlled Trial
McKay, H. G., Danaher, B. G., Seeley, J. R., Lichtenstein, E., & Gau, J. M. (2008) · Journal of Medical Internet Research · doi:10.2196/jmir.993 · Cited by 99
Williams, G. C., Patrick, H., Niemiec, C. P., Ryan, R. M., Deci, E. L., & Lavigne, H. M. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.03.002 · Cited by 100
Developing human laboratory models of smoking lapse behavior for medication screening
McKee, S. A. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00135.x · Cited by 93
Chronic Disease Management for Tobacco Dependence: A Randomized, Controlled Trial
Joseph, A. M. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.500 · Cited by 92
Burris, J. L., Studts, J. L., DeRosa, A. P., & Ostroff, J. S. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0257 · Cited by 90
Long-term outcomes of a cell phone–delivered intervention for smokers living with HIV/AIDS
Gritz, E. R., Danysh, H. E., Fletcher, F. E., Tami-Maury, I., Fingeret, M. C., King, R. M., Arduino, R. C., & Vidrine, D. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit349 · Cited by 89
A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings
Humfleet, G. L., Hall, S. M., Delucchi, K. L., & Dilley, J. W. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt005 · Cited by 89
Twardella, D., & Brenner, H. (2007) · Tobacco Control · doi:10.1136/tc.2006.016253 · Cited by 84
Carim-Todd, L., Mitchell, S. H., & Oken, B. S. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.014 · Cited by 82
Rukstalis, M., Jepson, C., Patterson, F., & Lerman, C. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.002 · Cited by 78
Webb, M. S., de Ybarra, D. R., Baker, E. A., Reis, I. M., & Carey, M. P. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0017669 · Cited by 79
Extended treatment with bupropion SR for cigarette smoking cessation
Killen, J. D., Fortmann, S. P., Murphy, G. M., Hayward, C., Arredondo, C., Cromp, D., Celio, M., Abe, L., Wang, Y., & Schatzberg, A. F. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.2.286 · Cited by 80
Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.
Robinson, J. D., Li, L., Chen, M., Lerman, C., Tyndale, R. F., Schnoll, R. A., Hawk, L. W., George, T. P., Benowitz, N. L., & Cinciripini, P. M. (2019) · Psychology of Addictive Behaviors · doi:10.1037/adb0000434 · Cited by 74
Brandon, T. H., Meade, C. D., Herzog, T. A., Chirikos, T. N., Webb, M. S., & Cantor, A. B. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.5.797 · Cited by 75
Louwagie, G. M. C., Okuyemi, K. S., & Ayo‐Yusuf, O. A. (2014) · Addiction · doi:10.1111/add.12671 · Cited by 72
Association of COMT Val108/158Met genotype with smoking cessation
Munafò, M. R., Johnstone, E. C., Guo, B., Murphy, M. F. G., & Aveyard, P. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f44daa · Cited by 68
Contingency management for smoking cessation among treatment-seeking patients in a community setting
Secades-Villa, R., García-Rodríguez, O., López-Núñez, C., Alonso-Pérez, F., & Fernández-Hermida, J. R. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.03.030 · Cited by 57
Using Decision Tree Analysis to Identify Risk Factors for Relapse to Smoking
Piper, M. E., Loh, W.-Y., Smith, S. S., Japuntich, S. J., & Baker, T. B. (2011) · Substance Use & Misuse · doi:10.3109/10826081003682222 · Cited by 53
Carpenter, M. J., Wahlquist, A. E., Dahne, J., Gray, K. M., Garrett‐Mayer, E., Cummings, K. M., Davis, R., & Egan, B. M. (2020) · Addiction · doi:10.1111/add.14953 · Cited by 50
Shuter, J., Morales, D. A., Considine-Dunn, S. E., An, L. C., & Stanton, C. A. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000226 · Cited by 51
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L. F., & Lancaster, T. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub4 · Cited by 46
Kim, S., Darwish, S., Lee, S. A., Sprague, C., & DeMarco, R. F. (2018) · International Journal of Women s Health · doi:10.2147/ijwh.s172669 · Cited by 45
“smoking abstinence Six-month prolonged abstinence was another primary outcome of the study and defined as continuous abstinence, except for the first 2-week grace period.(48) It was assessed by self-report at each follow-up and with biochemical verification at 3- and 6-month follow-ups.”
MethodMediators of a successful web‐based smokeless tobacco cessation program
Danaher, B. G., Smolkowski, K., Seeley, J. R., & Severson, H. H. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02295.x · Cited by 45
Bock, B. C., Dunsiger, S. I., Rosen, R. K., Thind, H., Jennings, E., Fava, J. L., Becker, B. M., Carmody, J., & Marcus, B. H. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty212 · Cited by 45
Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?
Ashare, R. L., Lerman, C., Tyndale, R. F., Hawk, L. W., George, T. P., Cinciripini, P., & Schnoll, R. A. (2017) · Journal of Smoking Cessation · doi:10.1017/jsc.2016.11 · Cited by 42
“Participants were coded as abstinent if they reported no smoking (not even a puff) since the TQD and if they provided biochemical verification (i.e., CO 8 ppm) (Hughes et al., 2003).”
BackgroundMethodInfluentialO'Cleirigh, C., Zvolensky, M. J., Smits, J. A. J., Labbe, A. K., Coleman, J. N., Wilner, J. G., Stanton, A. M., Gonzalez, A., Garey, L., Regenauer, K. S., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001787 · Cited by 41
Carpenter, M. J., Alberg, A. J., Gray, K. M., & Saladin, M. E. (2010) · Clinical Trials · doi:10.1177/1740774510361533 · Cited by 41
McClure, J. B., Derry, H., Riggs, K. R., Westbrook, E. W., St. John, J., Shortreed, S. M., Bogart, A., & An, L. C. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.06.009 · Cited by 33
“This measure is recommended in trials like Q2 where participants may not be actively trying to quit smoking [38].”
BackgroundCastro Santos, H., & Gama Marques, J. (2021) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000128 · Cited by 37
Gonzales, D., Jorenby, D. E., Brandon, T. H., Arteaga, C., & Lee, T. C. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03058.x · Cited by 37
Smit, E. S., Hoving, C., Cox, V. C. M., & de Vries, H. (2012) · Health Education Research · doi:10.1093/her/cyr099 · Cited by 35
“It might thus be that in our study, respondents who were relatively more addicted failed to quit smoking and therefore, as is also assumed by the using the recommended intention-to-treat approach [32, 33], dropped out of the study.”
ResultCost-Effectiveness of a Health System-Based Smoking Cessation Program
Levy, D. E., Klinger, E. V., Linder, J. A., Fleegler, E. W., Rigotti, N. A., Park, E. R., & Haas, J. S. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw243 · Cited by 34
Acceptance of cravings: How smoking cessation experiences affect craving beliefs
Nosen, E., & Woody, S. R. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.05.003 · Cited by 26
Nunes, E. V., Covey, L. S., Brigham, G., Hu, M.-C., Levin, F. R., Somoza, E. C., & Winhusen, T. M. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08155 · Cited by 22
Weiss de Souza, I. C., Kozasa, E. H., Bowen, S., Richter, K. P., Sartes, L. M. A., Colugnati, F. A. B., & Noto, A. R. (2020) · Nicotine and Tobacco Research · doi:10.1093/ntr/ntaa057 · Cited by 18
Dahne, J., Wahlquist, A. E., Boatright, A. S., Garrett-Mayer, E., Fleming, D. O., Davis, R., Egan, B., & Carpenter, M. J. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.07.008 · Cited by 16
Treatment Outcomes From a Specialist Model for Treating Tobacco Use Disorder in a Medical Center
Burke, M. V., Ebbert, J. O., Schroeder, D. R., McFadden, D. D., & Hays, J. T. (2015) · Medicine · doi:10.1097/md.0000000000001903 · Cited by 13
Haslam, R. L., Pezdirc, K., Truby, H., Attia, J., Hutchesson, M., Burrows, T., Callister, R., Hides, L., Bonevski, B., Kerr, D. A., et al. (2020) · JMIR Research Protocols · doi:10.2196/15999 · Cited by 13
Day, A. T., Tang, L., Karam-Hage, M., & Fakhry, C. (2019) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000522 · Cited by 12
Jirapramukpitak, T., Pattanaseri, K., Chua, K.-C., & Takizawa, P. (2020) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz106 · Cited by 11
Hecht, J., Rigotti, N. A., Minami, H., Kjome, K. L., Bloom, E. L., Kahler, C. W., Price, L. H., Levy, D. E., Carpenter, K. M., & Brown, R. A. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.06.001 · Cited by 7
Jacquart, J., Papini, S., Davis, M. L., Rosenfield, D., Powers, M. B., Frierson, G. M., Hopkins, L. B., Baird, S. O., Marcus, B. H., Church, T. S., et al. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.01.007 · Cited by 8
“Failure to maintain prolonged abstinence (PA) at any assessment was defined by 7 or more consecutive days of smoking or smoking at least 1 cigarette over the 2 consecutive weeks prior to the assessment (Hughes et al., 2003; Smits et al., 2016).”
Background
Metadata
- Authors
- Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E.
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 13-25
- ISSN
- 1462-2203 (ISSN-L)
- 1469-994X
- OpenAlex
- W2115129983
- Cited by
- 1,058
- References
- 53
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.